Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (5y) (2015 - 2022)
Powered by 
Analysis
Niagen Bioscience (NAGE) Interest Coverage Ratio Growth (5y) (2015 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Niagen Bioscience | 251.05 Mn | 184.31 Mn | 19.31 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2022 | -54.08% |
| Jun 30, 2022 | -182.46% |
| Mar 31, 2022 | -72.48% |
| Dec 31, 2021 | -37.93% |
| Sep 30, 2021 | -7.59% |
| Jun 30, 2021 | -235.32% |
| Mar 31, 2021 | -369.44% |
| Dec 31, 2020 | -177.01% |
| Sep 30, 2020 | -196.38% |
| Jun 30, 2020 | -156.02% |
| Sep 30, 2019 | 15.86% |
| Jun 30, 2019 | 38.02% |
| Mar 31, 2018 | -0.16% |
| Sep 30, 2017 | 20.56% |
| Jul 1, 2017 | 63.21% |
| Apr 1, 2017 | -16.20% |
| Dec 31, 2016 | -36.29% |
| Oct 1, 2016 | -5.11% |
| Jul 2, 2016 | 14.93% |
| Oct 3, 2015 | 15.00% |